Next-Generation Sequencing: An Emerging Tool for Drug Designing

Author(s): Pooja Tripathi, Jyotsna Singh, Jonathan A. Lal, Vijay Tripathi*.

Journal Name: Current Pharmaceutical Design

Volume 25 , Issue 31 , 2019

Abstract:

Background: With the outbreak of high throughput next-generation sequencing (NGS), the biological research of drug discovery has been directed towards the oncology and infectious disease therapeutic areas, with extensive use in biopharmaceutical development and vaccine production.

Method: In this review, an effort was made to address the basic background of NGS technologies, potential applications of NGS in drug designing. Our purpose is also to provide a brief introduction of various Nextgeneration sequencing techniques.

Discussions: The high-throughput methods execute Large-scale Unbiased Sequencing (LUS) which comprises of Massively Parallel Sequencing (MPS) or NGS technologies. The Next geneinvolved necessarily executes Largescale Unbiased Sequencing (LUS) which comprises of MPS or NGS technologies. These are related terms that describe a DNA sequencing technology which has revolutionized genomic research. Using NGS, an entire human genome can be sequenced within a single day.

Conclusion: Analysis of NGS data unravels important clues in the quest for the treatment of various lifethreatening diseases and other related scientific problems related to human welfare.

Keywords: Next generation sequencing, drug discovery, high throughput sequencing, infectious disease, human welfare, Large-scale Unbiased Sequencing (LUS).

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 25
ISSUE: 31
Year: 2019
Page: [3350 - 3357]
Pages: 8
DOI: 10.2174/1381612825666190911155508
Price: $58

Article Metrics

PDF: 12